Clinical Research Directory

Inclusion criteria related to the device characteristics: * Weight \< 100 kg. * Hip width between 30 - 45 cm. * Distance from the hip joint center to the knee joint center: 36 cm - 50 cm. * Distance from the knee joint center to the floor: 43.5 cm - 59.5 cm. * Patients must be able to follow simple instructions. * MAS \< 3 in lower limbs. * EU shoe size between 36 and 45. * Absence of pathology affecting movement (only valid for phase 1 of the current study). Inclusion criteria related to the study: * Age 18-85 years. * Diagnosis of stroke (ACV), acquired brain injury (DCA), multiple sclerosis (EM), muscular dystrophy (LM), or cerebral palsy (PC). * Gait difficulty: those who require assistance to walk using technical aids, assistance, or supervision from others. * FAC score in participants with DCA, stroke, or MS \< 4. * WISCI II score in participants with MD \< 20. Exclusion Criteria: * Spasticity (MAS) = 3 in lower limbs. * Skin alterations in the areas of contact with the device. * Planned surgical intervention during the study duration. * Two or more osteoporotic fractures in the lower limbs in the last 2 years. * Presence of other conditions that cause exercise intolerance (such as uncontrolled hypertension, coronary artery diseases, arrhythmia, congestive heart failure, severe lung disease). * Surgical operation in the 3 months prior to the start of the study on the limbs and/or spine. * Psychiatric disorders that interfere with proper use of the device or participation in the study, such as impulsivity or inability to understand simple instructions.